Mobile Electrocardiogram Monitoring for Detecting Arrhythmias in Children

Launched by CENTRO MEDICO TEKNON · Nov 28, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to monitor heart rhythms in children who have experienced symptoms like heart palpitations, fainting (syncope), or dizziness. Researchers want to see if using a mobile electrocardiogram (ECG) can effectively detect irregular heartbeats, or arrhythmias, compared to the traditional method, which includes regular doctor visits and a 24-hour Holter ECG test.

To take part in the study, children aged 5 to 18 who may have symptoms of heart rhythm issues can join, even if they do not have a known heart condition. Participants will need to have access to a smartphone, smartwatch, or tablet that works with the KARDIA mobile ECG monitoring system. They will also need permission from a parent or guardian if they are under 18. Throughout the trial, participants will have their heart rhythms monitored using the mobile device, helping researchers understand if this method is a good option for detecting heart problems in kids.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 5-18 years old with or without the diagnosis of structural heart disease and symptoms suggestive of rhythm disorders as follows: palpitations and/or syncope and/or dizziness.
• • 24-hours Holter without diagnosis of arrhythmia.
• • Having an smart phone, smart watch, or tablet (the patient itself or a family member who lives together with the patient) compatible with KARDIA mobile ECG monitoring.
• • Signed informed consent. In cases under the age of \<18 y.o informed consent should be signed by parents or guardians.
• Exclusion Criteria:
• • Concomitant investigation treatments.
• • Being already diagnosed for arrhythmic events.
• • Medical, geographical and social factors that make study participation impractical, and inability to give written informed consent.
• • Patient's refusal to participate in the study.